2023 Q3 Form 10-Q Financial Statement

#000162828023028326 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.299B $1.285B
YoY Change -6.77% 16.54%
Cost Of Revenue $883.8M $605.5M
YoY Change 23.8% 38.97%
Gross Profit $415.4M $679.2M
YoY Change -38.88% 1.87%
Gross Profit Margin 31.97% 52.87%
Selling, General & Admin $514.1M $599.1M
YoY Change -21.99% 17.66%
% of Gross Profit 123.76% 88.21%
Research & Development $234.3M $244.0M
YoY Change -3.66% 41.37%
% of Gross Profit 56.4% 35.92%
Depreciation & Amortization $45.30M $40.40M
YoY Change 51.51% 81.17%
% of Gross Profit 10.91% 5.95%
Operating Expenses $959.1M $883.5M
YoY Change 2.9% 25.48%
Operating Profit -$543.7M -$204.3M
YoY Change 115.33% 446.26%
Interest Expense -$34.00M -$24.60M
YoY Change -30.04% -64.3%
% of Operating Profit
Other Income/Expense, Net -$31.10M -$25.40M
YoY Change -38.42% -13.31%
Pretax Income -$577.0M -$228.9M
YoY Change 91.63% 115.33%
Income Tax -$33.40M -$22.90M
% Of Pretax Income
Net Earnings -$543.6M -$206.0M
YoY Change 111.52% 98.08%
Net Earnings / Revenue -41.84% -16.03%
Basic Earnings Per Share -$3.20 -$1.22
Diluted Earnings Per Share -$3.20 -$1.22
COMMON SHARES
Basic Shares Outstanding 169.8M shares 169.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $802.0M $885.0M
YoY Change -38.52% -32.27%
Cash & Equivalents $756.8M $775.8M
Short-Term Investments $45.00M $109.2M
Other Short-Term Assets $838.0M $667.9M
YoY Change -18.46% -21.82%
Inventory
Prepaid Expenses
Receivables $814.5M $622.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.537B $2.255B
YoY Change -21.97% -25.72%
LONG-TERM ASSETS
Property, Plant & Equipment $392.0M $405.9M
YoY Change 17.44% 35.21%
Goodwill $6.600B $6.769B
YoY Change -3.95% -6.34%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $201.2M $266.0M
YoY Change -16.96% -29.31%
Total Long-Term Assets $12.67B $13.27B
YoY Change -11.03% -9.78%
TOTAL ASSETS
Total Short-Term Assets $2.537B $2.255B
Total Long-Term Assets $12.67B $13.27B
Total Assets $15.21B $15.53B
YoY Change -13.07% -12.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $131.8M $127.5M
YoY Change -19.04% -36.22%
Accrued Expenses $1.316B $1.186B
YoY Change -24.09% -25.93%
Deferred Revenue $1.118B $991.5M
YoY Change -4.05% -8.17%
Short-Term Debt $373.1M $372.1M
YoY Change 6.6% 6.31%
Long-Term Debt Due $373.0M $372.1M
YoY Change
Total Short-Term Liabilities $3.000B $2.738B
YoY Change -13.47% -16.69%
LONG-TERM LIABILITIES
Long-Term Debt $2.707B $2.705B
YoY Change -7.78% -7.86%
Other Long-Term Liabilities $258.4M $231.4M
YoY Change -15.86% -19.43%
Total Long-Term Liabilities $2.966B $2.936B
YoY Change 865.65% 922.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.000B $2.738B
Total Long-Term Liabilities $2.966B $2.936B
Total Liabilities $6.777B $6.585B
YoY Change -15.91% -18.53%
SHAREHOLDERS EQUITY
Retained Earnings $414.7M $958.3M
YoY Change -78.49% -56.14%
Common Stock $9.185B $9.089B
YoY Change 4.82% 5.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.430B $8.940B
YoY Change
Total Liabilities & Shareholders Equity $15.21B $15.53B
YoY Change -13.07% -12.51%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$543.6M -$206.0M
YoY Change 111.52% 98.08%
Depreciation, Depletion And Amortization $45.30M $40.40M
YoY Change 51.51% 81.17%
Cash From Operating Activities $64.80M $5.000M
YoY Change 18.68% -95.04%
INVESTING ACTIVITIES
Capital Expenditures $28.40M $31.50M
YoY Change -149.91% -25.88%
Acquisitions $1.600M
YoY Change
Other Investing Activities $50.60M $2.600M
YoY Change -31.25% -100.09%
Cash From Investing Activities $22.20M $38.10M
YoY Change 32.93% -101.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.30M -$20.80M
YoY Change -143.18% -101.03%
NET CHANGE
Cash From Operating Activities 64.80M $5.000M
Cash From Investing Activities 22.20M $38.10M
Cash From Financing Activities -50.30M -$20.80M
Net Change In Cash 36.70M $26.10M
YoY Change -80.46% -103.71%
FREE CASH FLOW
Cash From Operating Activities $64.80M $5.000M
Capital Expenditures $28.40M $31.50M
Free Cash Flow $36.40M -$26.50M
YoY Change -67.35% -145.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 ttwo Allowance For Doubtful Accounts Sales Returns And Discounts
AllowanceForDoubtfulAccountsSalesReturnsAndDiscounts
1200000 usd
CY2023Q1 ttwo Allowance For Doubtful Accounts Sales Returns And Discounts
AllowanceForDoubtfulAccountsSalesReturnsAndDiscounts
1300000 usd
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1284700000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1102400000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
605500000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
435700000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
679200000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
666700000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
400900000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
272100000 usd
CY2023Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
244000000.0 usd
CY2022Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
172600000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
198200000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
237100000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40400000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22300000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.22
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
26000000.0 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-62800000 usd
CY2023Q2 ttwo Amortization Of Intellectual Property
AmortizationOfIntellectualProperty
249600000 usd
CY2022Q2 ttwo Amortization Of Intellectual Property
AmortizationOfIntellectualProperty
117600000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7000000.0 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
800000 usd
CY2022Q2 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-39600000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15700000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25000000.0 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-141300000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-214900000 usd
CY2023Q2 ttwo Increase Decrease In Software Development Costs And Licenses
IncreaseDecreaseInSoftwareDevelopmentCostsAndLicenses
125200000 usd
CY2022Q2 ttwo Increase Decrease In Software Development Costs And Licenses
IncreaseDecreaseInSoftwareDevelopmentCostsAndLicenses
83600000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14400000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67600000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-87400000 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-159500000 usd
CY2023Q2 ttwo Accounts Payable Accrued Expenses Income Taxes Payable And Other Liabilities
AccountsPayableAccruedExpensesIncomeTaxesPayableAndOtherLiabilities
-191800000 usd
CY2022Q2 ttwo Accounts Payable Accrued Expenses Income Taxes Payable And Other Liabilities
AccountsPayableAccruedExpensesIncomeTaxesPayableAndOtherLiabilities
18800000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5000000.0 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100800000 usd
CY2023Q2 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
800000 usd
CY2022Q2 us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
125600000 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
78000000.0 usd
CY2022Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
242800000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31500000 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42500000 usd
CY2023Q2 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5000000.0 usd
CY2022Q2 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5100000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1600000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3128100000 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2600000 usd
CY2022Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38100000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2807300000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
41300000 usd
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
53900000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18800000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11400000 usd
CY2023Q2 ttwo Payment For Settlement Of Convertible Notes
PaymentForSettlementOfConvertibleNotes
0 usd
CY2022Q2 ttwo Payment For Settlement Of Convertible Notes
PaymentForSettlementOfConvertibleNotes
1166800000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
999300000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3248900000 usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7500000 usd
CY2022Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
22600000 usd
CY2023Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
989600000 usd
CY2022Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
CY2023Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
500000 usd
CY2022Q2 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20800000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2017000000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3800000 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14700000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26100000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-704200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1234600000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2195300000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1260700000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1491100000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9042500000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-206000000.0 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
26000000.0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
900000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99400000 usd
CY2023Q2 ttwo Stock Issued During Period Value Restricted Stock Award Settlement
StockIssuedDuringPeriodValueRestrictedStockAwardSettlement
41300000 usd
CY2023Q2 ttwo Settlement Related To Employee Stock Purchase Plan
SettlementRelatedToEmployeeStockPurchasePlan
18500000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
200000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-104000000.0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
479700000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9662300000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1284700000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1102400000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1102400000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1284700000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1102400000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1284700000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1102400000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1027000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1114300000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
523900000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
439700000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1232200000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1158700000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
79900000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
79900000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
928600000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
86600000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
21500000 usd
CY2023Q2 ttwo Convertible Debt Current Fair Value Disclosures
ConvertibleDebtCurrentFairValueDisclosures
22100000 usd
CY2023Q2 ttwo Convertible Debt Noncurrent Fair Value Disclosures
ConvertibleDebtNoncurrentFairValueDisclosures
23500000 usd
CY2023Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
153800000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1133500000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
66600000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
27300000 usd
CY2023Q1 ttwo Convertible Debt Noncurrent Fair Value Disclosures
ConvertibleDebtNoncurrentFairValueDisclosures
44100000 usd
CY2023Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
140500000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8000000.0 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8000000.0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
109900000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
700000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
109200000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
189000000.0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000000.0 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
187000000.0 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
109900000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
109200000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
109900000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
109200000 usd
CY2023Q2 ttwo Derivative Notional Amount To Sell
DerivativeNotionalAmountToSell
257300000 usd
CY2023Q1 ttwo Derivative Notional Amount To Sell
DerivativeNotionalAmountToSell
224300000 usd
CY2023Q2 ttwo Derivative Notional Amount To Buy
DerivativeNotionalAmountToBuy
107000000.0 usd
CY2023Q1 ttwo Derivative Notional Amount To Buy
DerivativeNotionalAmountToBuy
51200000 usd
CY2023Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
3800000 usd
CY2022Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1600000 usd
CY2023Q2 ttwo Software Development Costs And Licenses Current
SoftwareDevelopmentCostsAndLicensesCurrent
34400000 usd
CY2023Q2 ttwo Software Development Costs And Licenses Noncurrent
SoftwareDevelopmentCostsAndLicensesNoncurrent
1189000000 usd
CY2023Q1 ttwo Software Development Costs And Licenses Current
SoftwareDevelopmentCostsAndLicensesCurrent
65900000 usd
CY2023Q1 ttwo Software Development Costs And Licenses Noncurrent
SoftwareDevelopmentCostsAndLicensesNoncurrent
1072200000 usd
CY2023Q2 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
18200000 usd
CY2022Q2 us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
19900000 usd
CY2023Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
539600000 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
510700000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
151600000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
177500000 usd
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
123800000 usd
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
132700000 usd
CY2023Q2 ttwo Deferred Acquisition Payments Current
DeferredAcquisitionPaymentsCurrent
97300000 usd
CY2023Q1 ttwo Deferred Acquisition Payments Current
DeferredAcquisitionPaymentsCurrent
82700000 usd
CY2023Q2 ttwo Accrued Licenses Current
AccruedLicensesCurrent
63400000 usd
CY2023Q1 ttwo Accrued Licenses Current
AccruedLicensesCurrent
63000000.0 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
46400000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
33000000.0 usd
CY2023Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
41200000 usd
CY2023Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
52400000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
123000000.0 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
173700000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1186300000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1225700000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2723500000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
18800000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2704700000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1744100000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
11100000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1733000000 usd
CY2023Q2 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
20400000 usd
CY2023Q2 ttwo Short Term Debt Gross
ShortTermDebtGross
372100000 usd
CY2023Q2 ttwo Short Term Debt Unamortized Discount Premium And Debt Issuance Costs Net
ShortTermDebtUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
0 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
372100000 usd
CY2023Q1 ttwo Short Term Debt Gross
ShortTermDebtGross
1350000000 usd
CY2023Q1 ttwo Short Term Debt Unamortized Discount Premium And Debt Issuance Costs Net
ShortTermDebtUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3200000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1346800000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
34500000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
20500000 usd
CY2023Q2 ttwo Debt Maturity Remainder Of Fiscal Year
DebtMaturityRemainderOfFiscalYear
350000000.0 usd
CY2023Q2 ttwo Debt Maturity Year One
DebtMaturityYearOne
21400000 usd
CY2023Q2 ttwo Debt Maturity Year Two
DebtMaturityYearTwo
1100000000 usd
CY2023Q2 ttwo Debt Maturity Year Three
DebtMaturityYearThree
29400000 usd
CY2023Q2 ttwo Debt Maturity Year Four
DebtMaturityYearFour
1100000000 usd
CY2023Q2 ttwo Debt Maturity After Year Four
DebtMaturityAfterYearFour
500000000.0 usd
CY2023Q2 ttwo Debt Gross Before Fair Value Adjustments
DebtGrossBeforeFairValueAdjustments
3100800000 usd
CY2023Q2 ttwo Debt Fair Value Adjustments
DebtFairValueAdjustments
-5200000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
3095600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-206000000.0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-104000000.0 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169400000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136500000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.22
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.22
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-22900000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2300000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.100
CY2023Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
25400000 usd
CY2023Q2 ttwo Effective Income Tax Rate Reconciliation Gegraphic Mix Of Earnings Amount
EffectiveIncomeTaxRateReconciliationGegraphicMixOfEarningsAmount
2400000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
5000000.0 usd
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-23-028326-index-headers.html Edgar Link pending
0001628280-23-028326-index.html Edgar Link pending
0001628280-23-028326.txt Edgar Link pending
0001628280-23-028326-xbrl.zip Edgar Link pending
a6302023ttwoex-31x1.htm Edgar Link pending
a6302023ttwoex-31x2.htm Edgar Link pending
a6302023ttwoex-32x1.htm Edgar Link pending
a6302023ttwoex-32x2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ttwo-20230630.htm Edgar Link pending
ttwo-20230630.xsd Edgar Link pending
ttwo-20230630_def.xml Edgar Link unprocessable
ttwo-20230630_pre.xml Edgar Link unprocessable
ttwo-20230630_lab.xml Edgar Link unprocessable
ttwo-20230630_htm.xml Edgar Link completed
ttwo-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable